abstract |
The present invention is useful for the treatment of CCR5-related diseases and disorders, e.g., inhibition of HIV replication, prevention or treatment of HIV infection, and treatment of the resulting acquired immune deficiency syndrome (AIDS). It relates to the compound represented by (I) or a pharmaceutically acceptable derivative thereof. [Chemical 1] |